Literature DB >> 8562918

Cellular regulation of the protein C pathway.

C T Esmon1, K Fukudome.   

Abstract

The protein C anticoagulant pathway regulates thrombin formation. The pathway is triggered when thrombin binds to the endothelial cell proteoglycan, thrombomodulin. Unlike thrombin, this complex is a potent activator of the protein C zymogen, but it cannot clot blood. Activated protein C binds to protein S on cell surfaces where it proteolytically inactivates coagulation factors Va and VIIIa. Activated protein C also binds to a newly identified endothelial protein C receptor. Congenital deficiencies in this pathway are associated with thrombotic disease, and inflammation can cause acquired deficiencies. Activated protein C appears to inhibit inflammation. Thus, this pathway modulates both coagulation and inflammation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8562918     DOI: 10.1006/scel.1995.0035

Source DB:  PubMed          Journal:  Semin Cell Biol        ISSN: 1043-4682


  4 in total

1.  Comparative effects of the human protein C activator, Protac, on the activated partial thromboplastin clotting times of plasmas, with special reference to the dog.

Authors:  I B Johnstone; C A Martin
Journal:  Can J Vet Res       Date:  2000-04       Impact factor: 1.310

2.  Acute inflammation is exacerbated in mice genetically predisposed to a severe protein C deficiency.

Authors:  Angelina J Lay; Deborah Donahue; Meng-Ju Tsai; Francis J Castellino
Journal:  Blood       Date:  2006-10-17       Impact factor: 22.113

3.  Prediction of solution structures of the Ca2+-bound gamma-carboxyglutamic acid domains of protein S and homolog growth arrest specific protein 6: use of the particle mesh Ewald method.

Authors:  L Perera; L Li; T Darden; D M Monroe; L G Pedersen
Journal:  Biophys J       Date:  1997-10       Impact factor: 4.033

4.  The endothelial cell protein C receptor augments protein C activation by the thrombin-thrombomodulin complex.

Authors:  D J Stearns-Kurosawa; S Kurosawa; J S Mollica; G L Ferrell; C T Esmon
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-17       Impact factor: 11.205

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.